FABBRI, Leonardo
 Distribuzione geografica
Continente #
NA - Nord America 7.163
AS - Asia 3.851
EU - Europa 1.909
SA - Sud America 622
Continente sconosciuto - Info sul continente non disponibili 149
AF - Africa 111
OC - Oceania 19
Totale 13.824
Nazione #
US - Stati Uniti d'America 6.957
SG - Singapore 1.359
CN - Cina 988
BR - Brasile 487
VN - Vietnam 441
IT - Italia 367
DE - Germania 323
UA - Ucraina 317
HK - Hong Kong 308
TR - Turchia 212
GB - Regno Unito 193
FI - Finlandia 161
BD - Bangladesh 121
SE - Svezia 115
FR - Francia 113
RU - Federazione Russa 100
JP - Giappone 97
CA - Canada 82
IN - India 78
ID - Indonesia 74
MX - Messico 70
PL - Polonia 48
AR - Argentina 41
ZA - Sudafrica 41
ES - Italia 29
IQ - Iraq 29
AT - Austria 28
NL - Olanda 25
VE - Venezuela 23
EC - Ecuador 21
AU - Australia 18
JM - Giamaica 17
PK - Pakistan 17
CZ - Repubblica Ceca 16
LT - Lituania 15
MA - Marocco 15
KE - Kenya 14
SA - Arabia Saudita 14
CO - Colombia 13
CL - Cile 12
DZ - Algeria 12
PY - Paraguay 12
MY - Malesia 11
PH - Filippine 11
EG - Egitto 9
KR - Corea 9
UZ - Uzbekistan 9
CH - Svizzera 8
JO - Giordania 8
BE - Belgio 7
CR - Costa Rica 7
GT - Guatemala 7
LB - Libano 7
TW - Taiwan 7
IL - Israele 6
IR - Iran 6
PE - Perù 6
TN - Tunisia 6
AZ - Azerbaigian 5
IE - Irlanda 5
KZ - Kazakistan 5
NI - Nicaragua 5
PT - Portogallo 5
RO - Romania 5
RS - Serbia 5
TH - Thailandia 5
AL - Albania 4
DK - Danimarca 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
BH - Bahrain 3
BO - Bolivia 3
EE - Estonia 3
GE - Georgia 3
HN - Honduras 3
NP - Nepal 3
OM - Oman 3
SV - El Salvador 3
TG - Togo 3
BG - Bulgaria 2
CG - Congo 2
GR - Grecia 2
HR - Croazia 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MK - Macedonia 2
PA - Panama 2
QA - Qatar 2
SN - Senegal 2
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CM - Camerun 1
CY - Cipro 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
Totale 13.662
Città #
Singapore 872
Ashburn 784
San Jose 522
Fairfield 473
Woodbridge 438
Santa Clara 365
Council Bluffs 310
Jacksonville 306
Beijing 304
Hong Kong 301
Houston 282
Chandler 267
Ann Arbor 189
Wilmington 177
Cambridge 172
Los Angeles 172
Seattle 159
Ho Chi Minh City 152
Izmir 131
New York 110
Nanjing 99
Hanoi 95
Princeton 92
Tokyo 92
Dallas 83
Munich 83
Lauterbourg 79
Milan 76
Helsinki 75
Buffalo 60
Jakarta 53
São Paulo 52
Mexico City 51
Shanghai 50
Warsaw 43
San Diego 40
Boardman 37
Addison 35
Hefei 35
Phoenix 35
Tianjin 35
Orem 33
Denver 31
Hebei 31
Nanchang 31
Atlanta 28
Rome 28
Chicago 27
Turku 27
Da Nang 26
Changsha 25
Shenyang 25
Chennai 24
Jiaxing 24
Montreal 23
London 22
Bremen 21
Rio de Janeiro 21
Toronto 21
Vienna 21
Dong Ket 20
Johannesburg 20
San Francisco 19
Brooklyn 18
Moscow 18
San Mateo 18
Frankfurt am Main 17
Norwalk 17
Nuremberg 17
Baghdad 16
Haiphong 15
Boston 14
Curitiba 14
Falkenstein 14
Naples 14
Philadelphia 14
Washington 14
Brasília 12
Dearborn 12
Guangzhou 12
Nairobi 12
Poplar 12
Charlotte 11
Genoa 11
Redwood City 11
Stockholm 11
Ankara 10
Belo Horizonte 10
Brno 10
Campinas 10
Ferrara 10
Hangzhou 10
Kingston 10
Manchester 10
Ningbo 10
Bologna 9
Can Tho 9
Dhaka 9
Jinan 9
Krasnodar 9
Totale 8.793
Nome #
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal 272
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 270
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease 254
Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57 252
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 250
Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis 227
Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure 218
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 215
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 212
CD-4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjogren's syndrome 211
Enfisema polmonare: prospettive di terapia 210
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 205
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 204
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC 203
Airway smooth muscle biochemistry and asthma 202
The distribution of Neurokinin-1 and Neurokinin-2 receptors in human central airways 202
Increased bronchial responsiveness in primary Sjogren's syndrome. A sign of tracheobronchial involvement 198
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 194
Helicobacter pylori and chronic bronchitis 193
Asthma progression and mortality: The role of inhaled corticosteroids 192
Inflammatory cells in the bronchial glands of smokers with chronic bronchitis 190
Anti-inflammatory treatments for asthma: Past, present, future 188
Inhaled corticosteroids in COPD: Friend or foe? 187
Increased xanthine oxidase activity in broncoalveolar lavage fluid from subject with chronic bronchitis 186
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal 186
Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis 183
Increased bronchial responsiveness in primary and secondary Sjogren's syndrome 180
Expression of monocyte chemoattractant protein-1 (MCP-1) and CC chemokine receptor 2 (CCR2B) by purified blood monocytes in smokers with lung cancer. 175
Altri problemi di patologia respiratoria 175
Oxygen radical production of broncho-alveolar lavage fluid (BALF) from subjects with chronic bronchitis. 175
Significant correlation between interleukin-10 expression and progression of non-small cell lung cancer through heme oxygenase 175
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD 174
Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues 174
Interleukin-6, but not pentraxin 3, predicts adverse clinical outcomes on short-term prognosis of patients with incipient heart failure 173
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease 171
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 171
Increased oxidant-induced clastogenic activity in bronchoalveolar lavage fluid obtained from subjects with chronic bronchitis. 170
Current controversies in chronic obstructive pulmonary disease: A report from the global initiative for chronic obstructive lung disease scientific committee 170
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease 165
Blood eosinophils for the management of COPD patients? 164
Prevention of Chronic Obstructive Pulmonary Disease 164
Integrin expression on neutrophils and mononuclear cells in blood and induced sputum in stable asthma 161
Espression of vasoactive intestinal peptide 1 receptor (VIPR1) in the central airways of smokers 159
Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study 157
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact 157
Inhaled corticosteroid containing combinations and mortality in COPD 155
Immunization and challenge with toulene diisocyanate decrease tachykinin and calcitonin gene-related peptide immunoreactivity in guinea pig central airways 152
Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications. 152
Production of superoxide radicals by bronchoalveolar lavage fluid obteined from patients with chronic bronchitis 151
Chronic cough in adults 150
What can we learn from late-onset and occupational asthma? 149
Xanthine oxidase in broncho-alveolar lavage fluid of subjects with chronic bronchitis. 148
Human leukocyyte antigen associations in occupational asthma induced by isocyanates 147
Sonicated serum damages human lymphocyte DNA: a model of free radicals induced cell injury 144
Mechanism of occupational asthma 141
A person-centred clinical approach to the multimorbid patient with COPD 139
COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer. Eur Resp J 2003; 22 Supp.45: 361s. 139
Neutrophils and asthma. 137
Severity of airflow limitation is associated with severity of airway inflammation in smokers 135
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation 132
Substance P and neurokinin-A in induced sputum from patients with chronic obstructive pulmonary disease. 131
Management of chronic refractory cough in adults 130
Very low density lipoproteins mediate DNA damage induced by sonicated serum on human lymphocytes. 129
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease 128
Neutrophils and Asthma 128
Similarities between mechanism of superoxide production in ultrasuond treated human serum and in BALF from patients with chronic bronchitis 128
Extrafine beclometasone dipropionate/ formoterol fumarate vs double bronchodilation therapy in patients with copd: A historical real-world non-inferiority study 127
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA 127
Mucin expression in the bronchiolar epithelium of patients with chronic obstructive pulmonary disease. 126
Glucocorticoidi 121
Evaluation by self-monitoring and noninvasive measures 118
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice 117
Guidelines and recommendations for the clinical use of bronchoalveolar lavage in asthma 117
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations 117
HLA class II molecules and asthma induced by toleune diisocyanate 115
Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients 114
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study 112
Influence of asbestos exposure on heme oxygenase(HO)-1 expression in lung tumour-associated macrophages. 169 (7): A411. 112
Small airway dysfunction: not so silent after all? 106
Inhaled long-acting muscarinic antagonists in asthma - A narrative review 106
Sex differences in asthma control, lung function and exacerbations: the ATLANTIS study 85
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS 84
Spirometry: A practical lifespan predictor of global health and chronic respiratory and non-respiratory diseases 81
Rate of Decline of FEV1 as Biomarker of Survival? 80
Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic Diseases 78
null 50
null 45
Clinical phenotyping of asthma patients with elevated sputum eosinophils and low blood eosinophils: a post-hoc analysis of the multicentre ATLANTIS cohort 14
The ROME COPD exacerbation proposal works! Time to move forward 13
Totale 13.824
Categoria #
all - tutte 67.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.014
Totale 69.983


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022667 0 0 0 61 61 25 25 46 36 55 71 287
2022/2023646 78 16 40 79 115 86 36 59 74 3 41 19
2023/2024391 42 48 20 15 25 54 13 25 15 5 11 118
2024/20251.796 38 59 155 47 238 161 29 61 282 224 272 230
2025/20265.400 568 223 437 662 784 358 642 276 536 554 244 116
2026/20271.236 151 306 527 252 0 0 0 0 0 0 0 0
Totale 13.824